Stock Analysis

Earnings growth outpaced the decent 34% return delivered to Baolingbao BiologyLtd (SZSE:002286) shareholders over the last year

SZSE:002286
Source: Shutterstock

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But investors can boost returns by picking market-beating companies to own shares in. For example, the Baolingbao Biology Co.,Ltd. (SZSE:002286) share price is up 33% in the last 1 year, clearly besting the market return of around 12% (not including dividends). That's a solid performance by our standards! On the other hand, longer term shareholders have had a tougher run, with the stock falling 30% in three years.

Since the stock has added CN¥292m to its market cap in the past week alone, let's see if underlying performance has been driving long-term returns.

See our latest analysis for Baolingbao BiologyLtd

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

Baolingbao BiologyLtd was able to grow EPS by 40% in the last twelve months. This EPS growth is significantly higher than the 33% increase in the share price. Therefore, it seems the market isn't as excited about Baolingbao BiologyLtd as it was before. This could be an opportunity.

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

earnings-per-share-growth
SZSE:002286 Earnings Per Share Growth March 18th 2025

Dive deeper into Baolingbao BiologyLtd's key metrics by checking this interactive graph of Baolingbao BiologyLtd's earnings, revenue and cash flow.

Advertisement

A Different Perspective

We're pleased to report that Baolingbao BiologyLtd shareholders have received a total shareholder return of 34% over one year. That's including the dividend. That gain is better than the annual TSR over five years, which is 2%. Therefore it seems like sentiment around the company has been positive lately. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. It's always interesting to track share price performance over the longer term. But to understand Baolingbao BiologyLtd better, we need to consider many other factors. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for Baolingbao BiologyLtd you should know about.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: many of them are unnoticed AND have attractive valuation).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

Valuation is complex, but we're here to simplify it.

Discover if Baolingbao BiologyLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.